New proteasome inhibitors in the treatment of multiple myeloma
Sign Up to like & getrecommendations! Published in 2019 at "Hematology, Transfusion and Cell Therapy"
DOI: 10.1016/j.htct.2018.07.003
Abstract: The treatment of patients with relapsed and/or refractory multiple myeloma has improved considerably in the last 15 years, after the introduction of proteasome inhibitors and immunomodulatory drugs. The first clinical trials with new proteasome inhibitors… read more here.
Keywords: multiple myeloma; proteasome inhibitors; inhibitors treatment; new proteasome ... See more keywords